- Home
- ACNB vs DNA Comparison
ACNB vs DNA Comparison
Compare ACNB & DNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACNB
- DNA
- Stock Information
- Founded
- ACNB 1857
- DNA 2008
- Country
- ACNB United States
- DNA United States
- Employees
- ACNB N/A
- DNA N/A
- Industry
- ACNB Major Banks
- DNA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- ACNB Finance
- DNA Health Care
- Exchange
- ACNB Nasdaq
- DNA Nasdaq
- Market Cap
- ACNB 468.6M
- DNA 529.8M
- IPO Year
- ACNB N/A
- DNA N/A
- Fundamental
- Price
- ACNB $49.50
- DNA $8.83
- Analyst Decision
- ACNB Strong Buy
- DNA Strong Sell
- Analyst Count
- ACNB 3
- DNA 1
- Target Price
- ACNB $50.67
- DNA $9.00
- AVG Volume (30 Days)
- ACNB 19.7K
- DNA 1.3M
- Earning Date
- ACNB 10-23-2025
- DNA 11-06-2025
- Dividend Yield
- ACNB 3.08%
- DNA N/A
- EPS Growth
- ACNB N/A
- DNA N/A
- EPS
- ACNB 3.34
- DNA N/A
- Revenue
- ACNB $136,676,000.00
- DNA $180,606,000.00
- Revenue This Year
- ACNB $41.47
- DNA N/A
- Revenue Next Year
- ACNB $3.31
- DNA $14.41
- P/E Ratio
- ACNB $14.78
- DNA N/A
- Revenue Growth
- ACNB 28.45
- DNA N/A
- 52 Week Low
- ACNB $35.70
- DNA $5.00
- 52 Week High
- ACNB $49.72
- DNA $17.58
- Technical
- Relative Strength Index (RSI)
- ACNB 65.89
- DNA 38.58
- Support Level
- ACNB $45.64
- DNA $7.36
- Resistance Level
- ACNB $48.90
- DNA $8.54
- Average True Range (ATR)
- ACNB 1.30
- DNA 0.64
- MACD
- ACNB 0.12
- DNA 0.05
- Stochastic Oscillator
- ACNB 88.78
- DNA 33.25
About ACNB ACNB Corporation
ACNB Corp provides banking, insurance, and financial services to businesses and consumers, through its wholly-owned subsidiaries, ACNB Bank and ACNB Insurance Services, Inc. The corporation has two reporting segments; the Banking segment which generates the majority of the revenue from banking and wealth management services, including trust and retail brokerage, and ACNB Insurance Services segment which offers a broad range of property and casualty, life and health insurance to both commercial and individual clients.
About DNA Ginkgo Bioworks Holdings Inc.
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering: where company provide biological R&D services for customers across a range of industries and Biosecurity: where it provide services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.